Regenaflex-K9

is anintra-muscular injectablethat provides unparalleled convenience to small- and mixed-animal veterinary practices. 

The Hilltop Bio Difference

Compared to older orthobiologics like PRP or stem cells that are variable, labor-intensive, and require special equipment, our therapies are consistent dose-to-dose and are ready to use in under a minute!

master
One-Step Prep: Ready to use in under a minute
master
No Variability: Consistent formulation delivers reliable results
master
100% Natural: Humanely sourced Birth tissues
master
Save Time & Money: no equipment or processing required
master
Off-the-Shelf: Long-term, room temperature storage
master
Quality: Manufactured under strict cGMP/cGTP guidelines

Uses

  • Non-healing wounds
  • Lameness associated with soft tissue injury (tendon, ligament, muscle)
  • Lameness secondary to osteoarthritis

Studies

References:

  1. Dinarello CA. Historical review of cytokines. Eur J Immunol 2007;37(Suppl1):S35-S45.
  2. Gelhorn A and Han A. The use of dehydrated human amnion/chorion membrane allograft injection for the treatment of tendinopathy or arthritis: A case series involving 40 patients. P M & R 2017;9:1236-1243.
  3. Gulati K, Guhathakurta S, Joshi J, et al. Cytokines and their role in health and disease: a brief overview. MOJ Immunol 2016;4(2):00121.
  4. Gupta A. Allogenic Amniotic Tissue for Treatment of Knee and Hip Osteoarthritis. Pharmaceuticals (Basel). 2022 Mar 26;15(4):404.
  5. Kimmerling, K.A., Gomoll, A.H., Farr, J. et al. Amniotic suspension allograft improves pain and function in a rat meniscal tear-induced osteoarthritis model. Arthritis Res Ther 24, 63 (2022).
  6. Shimberg, M. The use of amniotic-fluid concentrate in orthopedic conditions. Journal of Bone and Joint Surgery, Vol. 20 No. 1, January 1938. 
  7. Werber, B. Amniotic tissues for the Treatment of Chronic Plantar Fasciosis and Achilles Tendinosis. Journal of Sports Medicine 215, 219896, 2015.
  8. Williams, K. B., & Ehrhart, N. P. Regenerative medicine 2.0: extracellular vesicle–based therapeutics for musculoskeletal tissue regeneration. JAVMA, 2022; 260(7), 683-689.